Journal of Lipid Research · 2003 · 51 citations · 47 references
Life SciencesBiochemistryMolecular BiologyEnzymologyLipid BiochemistryProtein BiochemistryCholesterol MetabolismLipid MetabolismLipoprotein MetabolismProtein DegradationProteolytic EnzymesProteolytic ProcessingApolipoprotein FunctionApolipoprotein MetabolismCholesterol AccumulationCholesterol EffluxChymase BiologyHigh-density Lipoprotein MetabolismProteolysis AnalysisProteolytic Enzyme Activity
Mast cell chymase, a chymotrypsin-like neutral protease, can proteolyze HDL3. Here we studied the ability of rat and human chymase to proteolyze discoidal preβ-migrating reconstituted HDL particles (rHDLs) containing either apolipoprotein A-I (apoA-I) or apoA-II. Both chymases cleaved apoA-I in rHDL at identical sites, either at the N-terminus (Tyr18 or Phe33) or at the C-terminus (Phe225), so generating three major truncated polypeptides that remained bound to the rHDL. The cleavage sites were independent of the size of the rHDL particles, but small particles were more susceptible to degradation than bigger ones. Chymase-induced truncation of apoA-I yielded functionally compromised rHDL with reduced ability to promote cellular cholesterol efflux. In sharp contrast to apoA-I, apoA-II was resistant to degradation. However, when apoA-II was present in rHDL that also contained apoA-I, it was degraded by chymase.We conclude that chymase reduces the ability of apoA-I in discoidal rHDL particles to induce cholesterol efflux by cleaving off either its amino- or carboxy-terminal portion. This observation supports the concept that limited extracellular proteolysis of apoA-I is one pathophysiologic mechanism leading to the generation and maintenance of foam cells in atherosclerotic lesions. Mast cell chymase, a chymotrypsin-like neutral protease, can proteolyze HDL3. Here we studied the ability of rat and human chymase to proteolyze discoidal preβ-migrating reconstituted HDL particles (rHDLs) containing either apolipoprotein A-I (apoA-I) or apoA-II. Both chymases cleaved apoA-I in rHDL at identical sites, either at the N-terminus (Tyr18 or Phe33) or at the C-terminus (Phe225), so generating three major truncated polypeptides that remained bound to the rHDL. The cleavage sites were independent of the size of the rHDL particles, but small particles were more susceptible to degradation than bigger ones. Chymase-induced truncation of apoA-I yielded functionally compromised rHDL with reduced ability to promote cellular cholesterol efflux. In sharp contrast to apoA-I, apoA-II was resistant to degradation. However, when apoA-II was present in rHDL that also contained apoA-I, it was degraded by chymase. We conclude that chymase reduces the ability of apoA-I in discoidal rHDL particles to induce cholesterol efflux by cleaving off either its amino- or carboxy-terminal portion. This observation supports the concept that limited extracellular proteolysis of apoA-I is one pathophysiologic mechanism leading to the generation and maintenance of foam cells in atherosclerotic lesions. Chymases are neutral proteases whose specificity is chymotrypsin-like: peptide bonds are cleaved on the carbonyl side of a) aromatic residues with the order of preference Phe>Tyr>>Trp, and b) the branched aliphatic amino acids Val, Ileu, and Leu (1Caughey G.H. Chymase.in: Barrett A.J. Rawlings N.D. Woessner J.F. Handbook of Proteolytic Enzymes. Academic Press, San Diego1998: 66-70Google Scholar). These enzymes are produced mainly or exclusively by mast cells, and are also found in mast cells of the human arterial intima, the site of atherogenesis (2Kovanen P.T. Role of mast cells in atherosclerosis.Chem. Immunol. 1995; 62: 132-170Google Scholar). In atherosclerotic lesions, the mast cells are activated and release a fraction of their chymase-containing cytoplasmic secretory granules into their microenvironment, where chymase may act on extracellularly located substrates. Chymase of rat serosal mast cells (rat mast cell protease I) has been found to inhibit cholesterol efflux from macrophage foam cells (3Lee M. Lindstedt L. Kovanen P.T. Mast cell-mediated inhibition of reverse cholesterol transport.Arterioscl. Thromb. 1992; 12: 1329-1335Google Scholar). This finding emerged from studies in vitro concerning the effect of exocytosed rat mast cell granules (i.e., granule remnants) on the functional modification of HDL, and was the first to suggest that a neutral protease present in the arterial intima could block cholesterol transport from this tissue. The early studies demonstrated that when HDL3 is incubated with the chymase-containing granule remnants derived from degranulating rat serosal mast cells, it is rapidly proteolyzed and that after even a minimal degree of proteolysis, the net efflux of cholesterol promoted by HDL3 from macrophage foam cells is significantly inhibited (3Lee M. Lindstedt L. Kovanen P.T. Mast cell-mediated inhibition of reverse cholesterol transport.Arterioscl. Thromb. 1992; 12: 1329-1335Google Scholar). In this in vitro system, degradation by granule remnant-bound chymase of the LpA-I particles present in HDL3 or in human plasma inhibited the high-affinity component of cholesterol efflux because of specific depletion of the minor subpopulation of preβ1-HDL particles (4Lindstedt L. Lee M. Castro G.R. Fruchart J.C. Kovanen P.T. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.J. Clin. Invest. 1996; 97: 2174-2182Google Scholar, 5Lee M. von Eckardstein A. Lindstedt L. Assmann G. Kovanen P.T. Depletion of preβ1LpA-I and LpA-IV by mast cell chymase reduces the cholesterol efflux ability promoted by plasma.Arterioscler. Thromb. Vasc. Biol. 1999; 19: 1066-1074Google Scholar). Proteolysis of human plasma by granule remnant-bound chymase also depleted its contents of LpA-IV (5Lee M. von Eckardstein A. Lindstedt L. Assmann G. Kovanen P.T. Depletion of preβ1LpA-I and LpA-IV by mast cell chymase reduces the cholesterol efflux ability promoted by plasma.Arterioscler. Thromb. Vasc. Biol. 1999; 19: 1066-1074Google Scholar), another minor subpopulation of lipid-poor HDL that is responsible for the high-affinity efflux of cholesterol in apoA-I-deficient plasma (6von Eckardstein A. Huang Y. Wu S. Saadat Sarmadi A. Schwarz S. Steinmetz A. Assmann G. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma.Arterioscler. Thromb. Vasc. Biol. 1995; 15: 1755-1763Google Scholar). Recently we demonstrated, using monoclonal site-specific apoA-I antibodies, that degradation of HDL3 by granule remnant-bound chymase modified several epitopes of apoA-I that are involved in the efflux of cholesterol or in the activation of LCAT (7Lee M. Uboldi P. Giudice D. Catapano A.L. Kovanen P.T. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function.J. Lipid Res. 2000; 41: 975-984Google Scholar). Notably, after a minor degradation of HDL3 with chymase, a truncated form of apoA-I (26 kDa) and small lipid-free peptides had been formed (7Lee M. Uboldi P. Giudice D. Catapano A.L. Kovanen P.T. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function.J. Lipid Res. 2000; 41: 975-984Google Scholar). These changes were paralleled by a rapid modification of the apoA-I epitope specific to preβ1-HDL (8Fielding P.E. Kawano M. Catapano A.L. Zoppo A. Marcovina S. Fielding C.J. Unique epitope of apolipoprotein A-I expressed in pre-β-1 high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol.Biochemistry. 1994; 33: 6981-6985Google Scholar), and were accompanied by rapid loss of the ability of HDL3 to act as a cellular cholesterol acceptor. Interestingly, the proteolytically modified HDL3 retained its ability to induce cholesterol esterification via LCAT activation, suggesting a differential response to apoA-I proteolysis of the two main functions of HDL in reverse cholesterol transport. The experimental approach of the above studies did not allow us to draw conclusions regarding the specific cleavage sites of apoA-I in the poorly lipidated preβ-migrating species of the HDL3 fraction by chymase and its effect on their ability as cholesterol acceptors. Here, we performed further studies to characterize the digestion products associated with the chymase-induced modification of the cholesterol acceptor function of the major HDL apolipoproteins using a well-defined system of reconstituted HDL (rHDL) containing POPC and apoA-I or apoA-II as the sole apolipoprotein. These discoidal preβ-migrating rHDL particles are analogs of the precursors of the plasma α-migrating HDL, and have proven useful in studies on the relationships between the structure and function of HDL apolipoproteins and HDL subpopulations (9Calabresi L. Tedeschi G. Treu C. Ronchi S. Galbiati D. Airoldi S. Sirtori C.R. Marcel Y. Franceschini G. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL.J. Lipid Res. 2001; 42: 935-942Google Scholar, 10Calabresi L. Canavesi M. Bernini F. Franceschini G. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.Biochemistry. 1999; 38: 16307-16314Google Scholar, 11Bernini F. Calabresi L. Bonfadini G. Franceschini G. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.Biochim. Biophys. Acta. 1996; 1299: 103-109Google Scholar). We now extend the studies initially performed with rat chymase and compare the degradation patterns of apoA-I produced by chymase of rat or human origin. Thus, the present paper concerns: a) the cleavage sites produced by rat and human chymase on apoA-I or apoA-II contained in a homogeneous population of discoidal preβ-migrating rHDL, and b) the effect of chymase treatment on the cholesterol efflux efficiency of these particles. and were from the of mast cells were from the and of was with and the exocytosed granule were from the by as Kovanen P.T. from mast cells induce of density lipoproteins by via Lipid Res. 1992; 33: Scholar). The of granule remnants is expressed in of their or of their with as as M. Kovanen P.T. density lipoprotein degradation by secretory granules of rat mast Biol. Scholar). This chymase to bound to the of the granule remnants and so the chymase from in the of its L. Lee M. Kovanen P.T. Chymase bound to is resistant to its and of high density lipoproteins in aortic intimal 2001; Scholar). granule remnants rat chymase bound to the of exocytosed granule human chymase expressed in the cell system was by The was in a containing and for the HDL degradation The was at for one and was inhibited by of and apoA-II were from human as F. Calabresi L. Bonfadini G. Franceschini G. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.Biochim. Biophys. Acta. 1996; 1299: 103-109Google Scholar). preβ-migrating rHDL containing POPC and apoA-I or apoA-II with a of were by the A. of human apolipoprotein A-I with and cholesterol from Biol. Scholar). In the the was into rHDL, with lipid-free apolipoprotein containing apoA-I and apoA-II were as F. Calabresi L. Bonfadini G. Franceschini G. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.Biochim. Biophys. Acta. 1996; 1299: 103-109Google Scholar). The size of rHDL was by on using the the were with a and the size of the rHDL was with using and as The of the reconstituted particles are in POPC were by the for the rHDL, but the in the The of apolipoprotein rHDL was by with as (9Calabresi L. Tedeschi G. Treu C. Ronchi S. Galbiati D. Airoldi S. Sirtori C.R. Marcel Y. Franceschini G. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL.J. Lipid Res. 2001; 42: 935-942Google Scholar). The of rHDL was by M. S. for of serum Acta. Scholar), the was by the of A.L. with Biol. Scholar), with as of reconstituted of reconstituted in a rHDL, reconstituted effect of size on degradation of apoA-I by chymase we homogeneous rHDL containing apoA-I and POPC with of or containing or apoA-I by the A. of human apolipoprotein A-I with and cholesterol from Biol. Scholar), as L. Castro G.R. Marcel A-I in discoidal for Scholar). was from plasma by using The and of lipoproteins in human Clin. Invest. Scholar). was by of of density lipoprotein and of cholesterol in Scholar). by treatment with in of contained in plasma density Scholar), yielded of bound to with specific from to rHDL and rHDL were by the component by the as The of to high specific by to a Scholar). The of the lipoproteins, on was not after the In the apoA-I rHDL or apoA-II rHDL was incubated at in in the or of either granule remnant-bound chymase of granule or to for of up to the were rapidly by on the granule remnant-bound chymase from the the were at at for to the and the were inhibit was to the The were to and functional studies as The digestion products were by on using the system G. for the of in the from to Scholar). the peptide in the were either with or to The were with and the of were from the and to on a with a The molecular of the were by using a in a formed by a were The was with and from The and the were in a of in with to a of cells were from in containing The cells were after and in with and with and into at for in cells were with the cells were with by for in the of of in containing the were with and incubated with containing the cholesterol and the as were performed by to the macrophage in the in the or by POPC the of as in the rHDL. the were and at for The in was by the efflux was found to for up to of with the of rHDL containing apoA-I with in degradation of apoA-I, by the of peptides In of apoA-II with did not of the two of rHDL were incubated with the chymase contained in rat granule the degradation as by the of were identical to with the human The cleavage products by digestion of the two with either chymase were on of apoA-I rHDL with for up to yielded two major and to polypeptides with molecular of and was at of and its remained the after of and at its had The of apoA-I degradation was when were incubated with the rat chymase The of of apoA-I at the was by of the incubated with apoA-I was by at and by at of In the of rat chymase, apoA-I is degraded by after and by after of In contrast to apoA-I, the apoA-II in rHDL remained with either chymase for up to However, when apoA-I was also present in the rHDL in to apoA-I, was degraded by either chymase with are in that apoA-II was by the of with either chymase. the of digestion with chymase was by changes in rHDL size were in chymase. rHDL, of a major species with a of and a minor component of did not in size the the degree of degradation. changes were in the size of the apoA-II rHDL, mainly of particles with a of or in the size of the rHDL particles major was found in the effect of size on the efficiency of degradation of apoA-I by chymase, three homogeneous apoA-I rHDL particles were The three had of and and contained and apoA-I the three rHDL particles were with chymase, the degradation of apoA-I was the of degradation between the three particles, that apoA-I in the particles was to a than apoA-I in the or particles (9Calabresi L. Tedeschi G. Treu C. Ronchi S. Galbiati D. Airoldi S. Sirtori C.R. Marcel Y. Franceschini G. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL.J. Lipid Res. 2001; 42: 935-942Google Scholar), release of from macrophage foam cell The of of either apoA-I rHDL or apoA-II rHDL to in a in the release of from the cells, up to at the efflux to but the containing apoA-II were to induce the release of cell cholesterol more than the of of POPC the of as were present in the rHDL to a of cell cholesterol efflux of apoA-I rHDL with or with granule remnant-bound chymase at for up to in of cholesterol efflux into the The effect of the two enzymes was a effect after of In apoA-II cholesterol efflux was not inhibited by either chymase In with the above of the of cholesterol efflux promoted by apoA-I rHDL that of apoA-I rHDL with granule remnant-bound chymase or with for reduced their ability to act as cholesterol by at the of the and was between the two The cholesterol efflux was than the efflux promoted by POPC that the proteolysis of apoA-I in the did not the of cholesterol efflux by the apoA-I rHDL. of POPC with either chymase did not the cholesterol efflux by the In contrast to the effect of chymase on apoA-I rHDL of apoA-II rHDL for with either chymase to changes in the cellular efflux of cholesterol The cleavage sites in apoA-I were after for of apoA-I rHDL with either of chymase by of by and of the molecular of the digestion products by The was to the that the effect in the inhibition of the cholesterol efflux could after of with either chymase. and molecular that in the two with molecular of and their at and two polypeptides by cleavage of apoA-I, one in the carboxy-terminal and the in the of the and molecular that a at The cleavage sites in apoA-I were when apoA-I rHDL of and were with chymase, and also when apoA-I contained in rHDL was degraded by chymase, that the apoA-I cleavage is independent of size and apolipoprotein of by proteolysis of apoA-I of to their on the can found in In where more than one is of is to to on of to their on the can found in In where more than one is of is to to on in a The present that apoA-I in rHDL is susceptible to proteolysis by chymase, apoA-II is the also the digestion of apoA-I by chymase is from that for and independent of the of the and proteolysis of apoA-I by chymase reduces the ability of apoA-I rHDL to promote cholesterol efflux from studies have that apoA-I in high density Unique of apolipoprotein A-I to or in discoidal rHDL domains of apolipoprotein A-I high density Biol. is susceptible to digestion by a of and proteases that are found in the arterial intima, as high density Unique of apolipoprotein A-I to Scholar, domains of apolipoprotein A-I high density Biol. Scholar, D. The that apolipoprotein A-II in vitro of human plasma high-density with cells is Biol. Scholar), L. Kovanen P.T. and but not high density cholesterol efflux from human macrophage foam cells by truncation of the of apolipoprotein Biol. 1999; Scholar), and plasma high density Unique of apolipoprotein A-I to Scholar, L. Kovanen P.T. and cholesterol efflux from foam Biophys. Res. 2000; can also proteolyze apoA-I in Here we that human chymase apoA-I in discoidal preβ-migrating rHDL and a identical to that produced by rat chymase, the of the rat mast cell granule chymase as a that apoA-I proteolysis by the human mast cell apoA-II in plasma HDL is to degradation by rat chymase, and (4Lindstedt L. Lee M. Castro G.R. Fruchart J.C. Kovanen P.T. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.J. Clin. Invest. 1996; 97: 2174-2182Google Scholar, D. The that apolipoprotein A-II in vitro of human plasma high-density with cells is Biol. Scholar, of apolipoproteins in high density with Biophys. Acta. Scholar), it from apoA-I in its to digestion by the of the apoA-I in the to apoA-II L. Kovanen P.T. and but not high density cholesterol efflux from human macrophage foam cells by truncation of the of apolipoprotein Biol. 1999; Scholar). The present with rHDL containing either apoA-I or apoA-II as a component that chymase between apoA-I, is and is resistant to digestion by the However, when apoA-II is present in rHDL particles containing apoA-I it is degraded by chymase, changes in apoA-II in the rHDL, sites of cleavage that are in the apoA-II rHDL. of apoA-I rHDL by chymase three major one cleavage site is located in the carboxy-terminal of apoA-I (Phe225), the two are in the (Tyr18 and Interestingly, major to the size of a apoA-I at was This is as with and it is independent of the rHDL to proteolysis of the to of apoA-I, from to the of the has been in several studies with proteases domains of apolipoprotein A-I high density Biol. Scholar, L. Kovanen P.T. and but not high density cholesterol efflux from human macrophage foam cells by truncation of the of apolipoprotein Biol. 1999; Scholar, Y. A. of of apolipoprotein in and in reconstituted high density Biol. 1995; Scholar). This of the is in a of by of apolipoprotein Biophys. Acta. 2000; Scholar), may to the protease because of of structure A. G. C. D. M. M. between sites of limited proteolysis and in Scholar). In the structure of the of apoA-I a a more structure of truncated human apolipoprotein A-I a and Fruchart J.C. The epitopes of apolipoprotein A-I domains a Biol. Scholar). This may the more limited of this to In the present we that human and rat chymases apoA-I either at the or amino treatment of these with or the amino residues of the (9Calabresi L. Tedeschi G. Treu C. Ronchi S. Galbiati D. Airoldi S. Sirtori C.R. Marcel Y. Franceschini G. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL.J. Lipid Res. 2001; 42: 935-942Google Scholar). The cleavage sites of chymase at the N-terminus of apoA-I suggest that in this the sites by chymase are more than by or that the between chymase and apoA-I is from that of degradation. Interestingly, a paper Calabresi L. Tedeschi G. A. L. Sirtori C.R. apoA-I at the and the that macrophage also could apoA-I at the and and that the N-terminus cleavage is at a cleavage site also with chymase. The containing apoA-I were in cholesterol efflux from than the apoA-I rHDL particles. This of the apoA-I rHDL with the apoA-II were resistant to the of chymase retained their capacity to induce cholesterol efflux even after chymase the size of is to their capacity for cell cholesterol L. Canavesi M. Bernini F. Franceschini G. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.Biochemistry. 1999; 38: 16307-16314Google Scholar), we for the effect of chymase on the size of apoA-I rHDL. However, we found that chymase treatment did not the size of apoA-I rHDL particles, that the reduced efficiency of apoA-I rHDL for cell cholesterol efflux have been to apoA-I it is that the of apoA-I cleaved by chymase are involved in the of the apoA-I rHDL with the cell in the of cholesterol efflux. of cellular cholesterol is to via two between lipid-free apoA-I and specific sites on the cell with and generation of small preβ-migrating and a of lipidated apoA-I, of small HDL particles, with the and of cholesterol from the cell into the The first to by the S. of cellular molecular mechanism for cholesterol in cells and in the Biophys. Acta. 2000; Scholar), and the may the G.H. M. Cell cholesterol of and Lipid Res. 1999; Scholar). The role of apoA-I domains in cellular cholesterol efflux by either lipid-free or lipidated apoA-I has been by using monoclonal epitopes the apoA-I and by using or apoA-I C.J. of apolipoprotein A-I epitope for cholesterol efflux from Biol. 1994; Scholar, D. L. Identification of a of apolipoprotein A-I associated with the efflux of cholesterol to human serum and apolipoprotein A-I containing 1996; Scholar, P. M. P. Fruchart J.C. Castro G.R. of apolipoprotein A-I involved in its with Biophys. Acta. 1994; Scholar, D. F. Marcel of of human apolipoprotein A-I in the of high-density Scholar, Eckardstein A. Castro G. P. Fruchart J.C. G. Assmann G. of reconstituted high density lipoprotein containing human apolipoprotein A-I with and for reduced cholesterol efflux by Biol. Scholar, D. of cellular cholesterol and to apolipoprotein A-I Biol. 1996; Scholar, S. G.H. A-I modification and the of reconstituted high density lipoprotein particles in cellular cholesterol Biol. 1996; Scholar, A. M. S. amino in the of apolipoprotein A-I and cellular Thromb. Vasc. Biol. 2000; Scholar). suggest that in the C.J. of apolipoprotein A-I epitope for cholesterol efflux from Biol. 1994; Scholar, D. L. Identification of a of apolipoprotein A-I associated with the efflux of cholesterol to human serum and apolipoprotein A-I containing 1996; Scholar, P. M. P. Fruchart J.C. Castro G.R. of apolipoprotein A-I involved in its with Biophys. Acta. 1994; Scholar, D. F. Marcel of of human apolipoprotein A-I in the of high-density and Eckardstein A. Castro G. P. Fruchart J.C. G. Assmann G. of reconstituted high density lipoprotein containing human apolipoprotein A-I with and for reduced cholesterol efflux by Biol. Scholar, D. of cellular cholesterol and to apolipoprotein A-I Biol. 1996; Scholar, P. M. Marcel of the of apolipoprotein A-I cell and efflux in 1999; 38: of apoA-I may cholesterol efflux to lipidated apoA-I by with specific or in the cell In of the role of the apoA-I residues in cell cholesterol the cleavage of the by chymase could by the reduced cell cholesterol by or reconstituted The effect of cleavage in the of apoA-I is However, cleavage of the and of apoA-I has been found to for of rHDL to S. M. of high density and discoidal reconstituted HDL to the HDL of and apoA-I on Biol. 2000; Scholar). that of rHDL up to with either of chymase reduced the efflux of cell cholesterol and that this in the efflux to the of a in the Notably, this contained two digestion products of identical were formed by either of the first or the residues of apoA-I and so conclusions independent role of the or cleavage sites of chymase in the of cholesterol efflux. In the present that mast cell chymase proteolyzes apoA-I, but not in when apoA-II is the apolipoprotein present in rHDL. In when apoA-I was also present in the rHDL, more the HDL particles found in apoA-II was also The high degree of cleavage specificity of apoA-I by the rat and human chymase found one cleavage at the and two at the this to the small of neutral proteases that are found in plasma or in extracellular and can as in the of the structure and function of chymase digestion reduces the ability of apoA-I in small HDL particles to promote cholesterol efflux from macrophage foam lipid-poor particles with rapidly G.R. Fielding of cell-derived cholesterol into preβ-migrating high density Scholar). for chymase to have on the efflux of cellular the also the particles of chymase by degranulating mast cells (2Kovanen P.T. Role of mast cells in atherosclerosis.Chem. Immunol. 1995; 62: 132-170Google Scholar), and depletion of particles and of cholesterol efflux by chymase are in vitro (3Lee M. Lindstedt L. Kovanen P.T. Mast cell-mediated inhibition of reverse cholesterol transport.Arterioscl. Thromb. 1992; 12: 1329-1335Google Scholar, 5Lee M. von Eckardstein A. Lindstedt L. Assmann G. Kovanen P.T. Depletion of preβ1LpA-I and LpA-IV by mast cell chymase reduces the cholesterol efflux ability promoted by plasma.Arterioscler. Thromb. Vasc. Biol. 1999; 19: 1066-1074Google Scholar, M. Uboldi P. Giudice D. Catapano A.L. Kovanen P.T. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function.J. Lipid Res. 2000; 41: 975-984Google Scholar). chymase-containing mast cells have been in human atherosclerotic M. A. Kovanen P.T. mast cell granules apolipoprotein lipoproteins into in human arterial of and in Thromb. Vasc. Biol. 1995; 15: Scholar), further for the role of mast cells in the inhibition of the of reverse cholesterol transport in The above also for the more concept that extracellular degradation of apoA-I is one pathophysiologic mechanism leading to the generation and maintenance of foam cells in atherosclerotic lesions. The the for the chymase, and for This was by from the and the to This was also by from the to reconstituted HDL human chymase
47
The Handbook of proteolytic enzymes
A. John Barrett, Neil D. Rawlings, J. Frederick Woessner · 1998 · 1.1K citations
A new enzymatic method for determination of serum choline-containing phospholipids
Masaharu Takayama, Susumu Itoh, T. Nagasaki et al. · Clinica Chimica Acta · 1977 · 1.1K citations